House Committee on Oversight and Government Reform Chairman James Comer has raised concerns over the potential risks to national security and data privacy following the bankruptcy filing of 23andMe, Inc. The company, known for its direct-to-consumer genetic testing services, holds DNA data from millions of Americans.
In a recent committee hearing titled “Securing Americans’ Genetic Information: Privacy and National Security Concerns Surrounding 23andMe’s Bankruptcy Sale,” Chairman Comer highlighted the importance of protecting this sensitive information from misuse by foreign or domestic entities. He emphasized that "there is no legal or illegal pathway for foreign adversaries or hostile private entities to access, manipulate, or exploit Americans’ DNA."
The hearing follows 23andMe's voluntary Chapter 11 bankruptcy filing on March 23, 2025. Regeneron Pharmaceuticals announced an asset purchase agreement with the company on May 19, but the court reopened the auction for final bids from Regeneron and TTAM Research Institute on June 4.
Chairman Comer expressed concern about potential future ownership and control of 23andMe's extensive genetic database. He noted that "serious concerns" exist regarding how this private information will be stored and used. There are fears it could fall into the hands of foreign adversaries through investment or partnerships.
The company's past engagement with foreign entities has also been scrutinized. In 2015, WuXi Healthcare Ventures invested $115 million in 23andMe. Although this partnership was later terminated, questions remain about future alliances.
Concerns extend beyond foreign actors to include possible misuse of genetic data for discriminatory practices in insurance, credit assessments, and targeted advertising based on health predispositions.
Chairman Comer underscored the need for legislative solutions to protect Americans' genetic information long-term. He anticipates testimony from Anne Wojcicki, co-founder and former CEO of 23andMe who is involved in bidding during the bankruptcy sale process.
Witnesses at the hearing are expected to provide insights while adhering to court-mandated restrictions related to ongoing bankruptcy proceedings.
